Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV/HCV coinfection
AUTOR(ES)
Wahle, Raul Carlos, Perez, Renata Mello, Pereira, Patrícia Fucuta, Oliveira, Elze Maria Gomes, Emori, Christini Takemi, Uehara, Silvia Naomi de Oliveira, Silva, Ivonete Sandra de Souza, Silva, Antônio Eduardo Benedito, Ferraz, Maria Lucia Gomes
FONTE
Braz J Infect Dis
DATA DE PUBLICAÇÃO
2015-10
RESUMO
ABSTRACTIn coinfected HBV/HCV patients, HBV replication is usually suppressed by HCV over the time. No study to date has evaluated the HBV viremia in long-term follow-up after HCV treatment in hemodialysis patients with HBV/HCV coinfection. This study aimed to assess the evolution of HBV viremia after HCV treatment in this special population. Ten hemodialysis patients with HBV/HCV coinfection with dominant HCV infection (HBV lower than 2000 IU/mL) and significant fibrosis were treated with interferon-alpha 3 MU 3×/week for 12 months and could be followed for at least 36 months after HCV treatment. Six cases of HBV reactivation (60%) during follow-up were observed and 5/6 had been successfully treated for HCV. Patients with HBV reactivation received anti-HBV therapy. Our preliminary findings indicate that treatment of hepatitis C in HBV/HCV coinfected hemodialysis patients may favor HBV reactivation. Thus, continued monitoring of HBV viremia must be recommended and prompt anti-HBV therapy should be implemented.
Documentos Relacionados
- HCV virological response during treatment of chronic hepatitis C is associated with liver histological Improvement in patients with HCV/HIV co-infection
- Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil
- Co-infection with hepatitis B virus and hepatitis C virus
- Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus.
- Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection